Cover Image
Market Research Report
Product code 
1044953

Global Mesalazine Market Size Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

Published: | QYResearch | 142 Pages | Delivery time: 2-3 business days

Price

Back to Top
Global Mesalazine Market Size Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027
Published: January 5, 2022
QYResearch
Content info: 142 Pages
Delivery time: 2-3 business days
  • ALL
  • Description
  • Table of Contents
Description

Market Analysis and Insights:

In 2020, the global Mesalazine market size was US$ 160.54 million and is forecast to US$ 210.03 million in 2027, growing at a CAGR of 4.44% during the forecast period. In this study, 2021 has been considered as the base year and 2021 to 2027 as the forecast period to estimate the market size for Mesalazine.

Scope and Market Size:

Mesalazine market is segmented by region, by country, by company, by Type, by Application and by sales channels. Players, stakeholders, and other participants in the global Mesalazine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region, by country, company, type, application and by sales channels for the period 2016-2027.

By Company

  • PharmaZell
  • Syntese A/S
  • Cambrex Corporation
  • Divis Laboratories
  • Chemi SpA
  • Ipca Laboratories
  • Hangzhou Brother
  • Lianyungang Fengheng Biopharm
  • Lasa Loboratory
  • Corden Pharma Bergamo
  • Erregierre SpA
  • CTX Lifescience
  • Ishita Active Pharma Ingredients
  • YC Biotech (Jiangsu)
  • Xinxiang Tianfeng Fine Chemical

Segment by Type

  • Purity ≤97%
  • Purity ≤98%
  • Purity ≤99%

Segment by Application

  • Tablets
  • Capsules
  • Pellet and Granule
  • Suppository
  • Enema
  • Others

By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • SEA
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of SA
  • Middle East & Africa
    • GCC Countries
    • Israel
    • Iran
    • South Africa
    • Rest of MEA
Table of Contents

TABLE OF CONTENTS

1 STUDY COVERAGE

  • 1.1 Mesalazine Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Mesalazine Market Size Growth Rate by Type
    • 1.2.2 Purity ≤97%
    • 1.2.3 Purity ≤98%
    • 1.2.4 Purity ≤99%
  • 1.3 Market by Application
    • 1.3.1 Global Mesalazine Market Size Growth Rate by Application
    • 1.3.2 Mesalazine Drug Information
    • 1.3.3 Tablets
    • 1.3.4 Capsules
    • 1.3.5 Pellet and Granule
    • 1.3.6 Suppository
    • 1.3.7 Enema
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 EXECUTIVE SUMMARY

  • 2.1 Global Mesalazine Market Size Estimates and Forecasts
    • 2.1.1 Global Mesalazine Revenue 2016-2027
    • 2.1.2 Global Mesalazine Sales 2016-2027
  • 2.2 Mesalazine Market Size by Region: 2021 Versus 2027
  • 2.3 Mesalazine Sales by Region (2016-2027)
    • 2.3.1 Global Mesalazine Sales by Region: 2016-2021
    • 2.3.2 Global Mesalazine Sales Forecast by Region (2022-2027)
    • 2.3.3 Global Mesalazine Sales Market Share by Region (2016-2027)
  • 2.4 Mesalazine Market Estimates and Projections by Region (2022-2027)
    • 2.4.1 Global Mesalazine Revenue by Region: 2016-2021
    • 2.4.2 Global Mesalazine Revenue Forecast by Region (2022-2027)
    • 2.4.3 Global Mesalazine Revenue Market Share by Region (2016-2027)

3 GLOBAL MESALAZINE BY MANUFACTURERS

  • 3.1 Global Top Mesalazine Manufacturers by Sales
    • 3.1.1 Global Mesalazine Sales by Manufacturer (2016-2021)
    • 3.1.2 Global Mesalazine Sales Market Share by Manufacturer (2016-2021)
  • 3.2 Global Top Mesalazine Manufacturers by Revenue
    • 3.2.1 Global Mesalazine Revenue by Manufacturer (2016-2021)
    • 3.2.2 Global Mesalazine Revenue Share by Manufacturer (2016-2021)
  • 3.3 Global Mesalazine Price by Manufacturer (2016-2021)
  • 3.4 Competitive Landscape
    • 3.4.1 Key Mesalazine Manufacturers Covered: Ranking by Revenue
    • 3.4.2 Global Mesalazine Market Concentration Ratio (CR5 and HHI) & (2016-2021)
    • 3.4.3 Global Mesalazine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.5 Global Mesalazine Manufacturing Base Distribution, Product Type
    • 3.5.1 Mesalazine Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.5.2 Manufacturers Mesalazine Product Type
    • 3.5.3 Established Date of International Manufacturers in Mesalazine Market
  • 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 COMPANY PROFILES

  • 4.1 PharmaZell
    • 4.1.1 PharmaZell Corporation Information
    • 4.1.2 PharmaZell Description, Business Overview
    • 4.1.3 PharmaZell Mesalazine Products Offered
    • 4.1.4 PharmaZell Mesalazine Sales, Revenue and Gross Margin (2016-2021)
    • 4.1.5 PharmaZell Mesalazine Revenue by Product
    • 4.1.6 PharmaZell Mesalazine Revenue by Application
    • 4.1.7 PharmaZell Mesalazine Revenue by Geographic Area
    • 4.1.8 PharmaZell Mesalazine Revenue by Sales Channel
    • 4.1.9 PharmaZell Recent Developments
  • 4.2 Syntese A/S
    • 4.2.1 Syntese A/S Corporation Information
    • 4.2.2 Syntese A/S Description, Business Overview
    • 4.2.3 Syntese A/S Mesalazine Products Offered
    • 4.2.4 Syntese A/S Mesalazine Sales, Revenue and Gross Margin (2016-2021)
    • 4.2.5 Syntese A/S Mesalazine Revenue by Product
    • 4.2.6 Syntese A/S Mesalazine Revenue by Application
    • 4.2.7 Syntese A/S Mesalazine Revenue by Geographic Area
    • 4.2.8 Syntese A/S Mesalazine Revenue by Sales Channel
  • 4.3 Cambrex Corporation
    • 4.3.1 Cambrex Corporation Information
    • 4.3.2 Cambrex Corporation Description, Business Overview
    • 4.3.3 Cambrex Corporation Mesalazine Products Offered
    • 4.3.4 Cambrex Corporation Mesalazine Sales, Revenue and Gross Margin (2016-2021)
    • 4.3.5 Cambrex Corporation Mesalazine Revenue by Product
    • 4.3.6 Cambrex Corporation Mesalazine Revenue by Application
    • 4.3.7 Cambrex Corporation Mesalazine Revenue by Geographic Area
    • 4.3.8 Cambrex Corporation Mesalazine Revenue by Sales Channel
    • 4.3.9 Cambrex Corporation Recent Developments
  • 4.4 Divis Laboratories
    • 4.4.1 Divis Laboratories Corporation Information
    • 4.4.2 Divis Laboratories Description, Business Overview
    • 4.4.3 Divis Laboratories Mesalazine Products Offered
    • 4.4.4 Divis Laboratories Mesalazine Sales, Revenue and Gross Margin (2016-2021)
    • 4.4.5 Divis Laboratories Mesalazine Revenue by Product
    • 4.4.6 Divis Laboratories Mesalazine Revenue by Application
    • 4.4.7 Divis Laboratories Mesalazine Revenue by Geographic Area
    • 4.4.8 Divis Laboratories Mesalazine Revenue by Sales Channel
  • 4.5 Chemi SpA
    • 4.5.1 Chemi SpA Corporation Information
    • 4.5.2 Chemi SpA Description, Business Overview
    • 4.5.3 Chemi SpA Mesalazine Products Offered
    • 4.5.4 Chemi SpA Mesalazine Sales, Revenue and Gross Margin (2016-2021)
    • 4.5.5 Chemi SpA Mesalazine Revenue by Product
    • 4.5.6 Chemi SpA Mesalazine Revenue by Application
    • 4.5.7 Chemi SpA Mesalazine Revenue by Geographic Area
    • 4.5.8 Chemi SpA Mesalazine Revenue by Sales Channel
  • 4.6 Ipca Laboratories
    • 4.6.1 Ipca Laboratories Corporation Information
    • 4.6.2 Ipca Laboratories Description, Business Overview
    • 4.6.3 Ipca Laboratories Mesalazine Products Offered
    • 4.6.4 Ipca Laboratories Mesalazine Sales, Revenue and Gross Margin (2016-2021)
    • 4.6.5 Ipca Laboratories Mesalazine Revenue by Product
    • 4.6.6 Ipca Laboratories Mesalazine Revenue by Application
    • 4.6.7 Ipca Laboratories Mesalazine Revenue by Geographic Area
    • 4.6.8 Ipca Laboratories Mesalazine Revenue by Sales Channel
  • 4.7 Hangzhou Brother
    • 4.7.1 Hangzhou Brother Corporation Information
    • 4.7.2 Hangzhou Brother Description, Business Overview
    • 4.7.3 Hangzhou Brother Mesalazine Products Offered
    • 4.7.4 Hangzhou Brother Mesalazine Sales, Revenue and Gross Margin (2016-2021)
    • 4.7.5 Hangzhou Brother Mesalazine Revenue by Product
    • 4.7.6 Hangzhou Brother Mesalazine Revenue by Application
    • 4.7.7 Hangzhou Brother Mesalazine Revenue by Geographic Area
    • 4.7.8 Hangzhou Brother Mesalazine Revenue by Sales Channel
  • 4.8 Lianyungang Fengheng Biopharm
    • 4.8.1 Lianyungang Fengheng Biopharm Corporation Information
    • 4.8.2 Lianyungang Fengheng Biopharm Description, Business Overview
    • 4.8.3 Lianyungang Fengheng Biopharm Mesalazine Products Offered
    • 4.8.4 Lianyungang Fengheng Biopharm Mesalazine Sales, Revenue and Gross Margin (2016-2021)
    • 4.8.5 Lianyungang Fengheng Biopharm Mesalazine Revenue by Product
    • 4.8.6 Lianyungang Fengheng Biopharm Mesalazine Revenue by Application
    • 4.8.7 Lianyungang Fengheng Biopharm Mesalazine Revenue by Geographic Area
    • 4.8.8 Lianyungang Fengheng Biopharm Mesalazine Revenue by Sales Channel
  • 4.9 Lasa Loboratory
    • 4.9.1 Lasa Loboratory Corporation Information
    • 4.9.2 Lasa Loboratory Description, Business Overview
    • 4.9.3 Lasa Loboratory Mesalazine Products Offered
    • 4.9.4 Lasa Loboratory Mesalazine Sales, Revenue and Gross Margin (2016-2021)
    • 4.9.5 Lasa Loboratory Mesalazine Revenue by Product
    • 4.9.6 Lasa Loboratory Mesalazine Revenue by Application
    • 4.9.7 Lasa Loboratory Mesalazine Revenue by Geographic Area
    • 4.9.8 Lasa Loboratory Mesalazine Revenue by Sales Channel
  • 4.10 Corden Pharma Bergamo
    • 4.10.1 Corden Pharma Bergamo Corporation Information
    • 4.10.2 Corden Pharma Bergamo Description, Business Overview
    • 4.10.3 Corden Pharma Bergamo Mesalazine Products Offered
    • 4.10.4 Corden Pharma Bergamo Mesalazine Sales, Revenue and Gross Margin (2016-2021)
    • 4.10.5 Corden Pharma Bergamo Mesalazine Revenue by Product
    • 4.10.6 Corden Pharma Bergamo Mesalazine Revenue by Application
    • 4.10.7 Corden Pharma Bergamo Mesalazine Revenue by Geographic Area
    • 4.10.8 Corden Pharma Bergamo Mesalazine Revenue by Sales Channel
    • 4.10.9 Corden Pharma Bergamo Recent Developments
  • 4.11 Erregierre SpA
    • 4.11.1 Erregierre SpA Corporation Information
    • 4.11.2 Erregierre SpA Description, Business Overview
    • 4.11.3 Erregierre SpA Mesalazine Products Offered
    • 4.11.4 Erregierre SpA Mesalazine Sales, Revenue and Gross Margin (2016-2021)
    • 4.11.5 Erregierre SpA Mesalazine Revenue by Product
    • 4.11.6 Erregierre SpA Mesalazine Revenue by Application
    • 4.11.7 Erregierre SpA Mesalazine Revenue by Geographic Area
    • 4.11.8 Erregierre SpA Mesalazine Revenue by Sales Channel
  • 4.12 CTX Lifescience
    • 4.12.1 CTX Lifescience Corporation Information
    • 4.12.2 CTX Lifescience Description, Business Overview
    • 4.12.3 CTX Lifescience Mesalazine Products Offered
    • 4.12.4 CTX Lifescience Mesalazine Sales, Revenue and Gross Margin (2016-2021)
    • 4.12.5 CTX Lifescience Mesalazine Revenue by Product
    • 4.12.6 CTX Lifescience Mesalazine Revenue by Application
    • 4.12.7 CTX Lifescience Mesalazine Revenue by Geographic Area
    • 4.12.8 CTX Lifescience Mesalazine Revenue by Sales Channel
  • 4.13 Ishita Active Pharma Ingredients
    • 4.13.1 Ishita Active Pharma Ingredients Corporation Information
    • 4.13.2 Ishita Active Pharma Ingredients Description, Business Overview
    • 4.13.3 Ishita Active Pharma Ingredients Mesalazine Products Offered
    • 4.13.4 Ishita Active Pharma Ingredients Mesalazine Sales, Revenue and Gross Margin (2016-2021)
    • 4.13.5 Ishita Active Pharma Ingredients Mesalazine Revenue by Product
    • 4.13.6 Ishita Active Pharma Ingredients Mesalazine Revenue by Application
    • 4.13.7 Ishita Active Pharma Ingredients Mesalazine Revenue by Geographic Area
    • 4.13.8 Ishita Active Pharma Ingredients Mesalazine Revenue by Sales Channel
  • 4.14 YC Biotech (Jiangsu)
    • 4.14.1 YC Biotech (Jiangsu) Corporation Information
    • 4.14.2 YC Biotech (Jiangsu) Description, Business Overview
    • 4.14.3 YC Biotech (Jiangsu) Mesalazine Products Offered
    • 4.14.4 YC Biotech (Jiangsu) Mesalazine Sales, Revenue and Gross Margin (2016-2021)
    • 4.14.5 YC Biotech (Jiangsu) Mesalazine Revenue by Product
    • 4.14.6 YC Biotech (Jiangsu) Mesalazine Revenue by Application
    • 4.14.7 YC Biotech (Jiangsu) Mesalazine Revenue by Geographic Area
    • 4.14.8 YC Biotech (Jiangsu) Mesalazine Revenue by Sales Channel
  • 4.15 Xinxiang Tianfeng Fine Chemical
    • 4.15.1 Xinxiang Tianfeng Fine Chemical Corporation Information
    • 4.15.2 Xinxiang Tianfeng Fine Chemical Description, Business Overview
    • 4.15.3 Xinxiang Tianfeng Fine Chemical Mesalazine Products Offered
    • 4.15.4 Xinxiang Tianfeng Fine Chemical Mesalazine Sales, Revenue and Gross Margin (2016-2021)
    • 4.15.5 Xinxiang Tianfeng Fine Chemical Mesalazine Revenue by Product
    • 4.15.6 Xinxiang Tianfeng Fine Chemical Mesalazine Revenue by Application
    • 4.15.7 Xinxiang Tianfeng Fine Chemical Mesalazine Revenue by Geographic Area
    • 4.15.8 Xinxiang Tianfeng Fine Chemical Mesalazine Revenue by Sales Channel

5 BREAKDOWN DATA BY TYPE

  • 5.1 Global Mesalazine Sales by Type (2016-2027)
    • 5.1.1 Global Mesalazine Sales by Type (2016-2021)
    • 5.1.2 Global Mesalazine Sales Forecast by Type (2022-2027)
    • 5.1.3 Global Mesalazine Sales Market Share by Type (2016-2027)
  • 5.2 Global Mesalazine Revenue Forecast by Type (2016-2027)
    • 5.2.1 Global Mesalazine Revenue by Type (2016-2021)
    • 5.2.2 Global Mesalazine Revenue Forecast by Type (2022-2027)
    • 5.2.3 Global Mesalazine Revenue Market Share by Type (2016-2027)
  • 5.3 Mesalazine Average Selling Price (ASP) by Type (2016-2027)

6 BREAKDOWN DATA BY APPLICATION

  • 6.1 Global Mesalazine Sales by Application (2016-2027)
    • 6.1.1 Global Mesalazine Sales by Application (2016-2021)
    • 6.1.2 Global Mesalazine Sales Forecast by Application (2022-2027)
    • 6.1.3 Global Mesalazine Sales Market Share by Application (2016-2027)
  • 6.2 Global Mesalazine Revenue Forecast by Application (2016-2027)
    • 6.2.1 Global Mesalazine Revenue by Application (2016-2021)
    • 6.2.2 Global Mesalazine Revenue Forecast by Application (2022-2027)
    • 6.2.3 Global Mesalazine Revenue Market Share by Application (2016-2027)
  • 6.3 Mesalazine Average Selling Price (ASP) by Application (2016-2027)

7 NORTH AMERICA

  • 7.1 North America Mesalazine Market Size YoY Growth 2016-2027
  • 7.2 North America Mesalazine Market Facts & Figures by Country
    • 7.2.1 North America Mesalazine Sales by Country (2016-2027)
    • 7.2.2 North America Mesalazine Revenue by Country (2016-2027)
  • 7.3 North America Mesalazine Sales by Type
  • 7.4 North America Mesalazine Sales by Application

8 ASIA-PACIFIC

  • 8.1 Asia-Pacific Mesalazine Market Size YoY Growth 2016-2027
  • 8.2 Asia-Pacific Mesalazine Market Facts & Figures by Region
    • 8.2.1 Asia-Pacific Mesalazine Sales by Region (2016-2027)
    • 8.2.2 Asia-Pacific Mesalazine Revenue by Region (2016-2027)
  • 8.3 Asia-Pacific Mesalazine Sales by Type
  • 8.4 Asia-Pacific Mesalazine Sales by Application

9 EUROPE

  • 9.1 Europe Mesalazine Market Size YoY Growth 2016-2027
  • 9.2 Europe Mesalazine Market Facts & Figures by Country
    • 9.2.1 Europe Mesalazine Sales by Country (2016-2027)
    • 9.2.2 Europe Mesalazine Revenue by Country (2016-2027)
  • 9.3 Europe Mesalazine Sales by Type
  • 9.4 Europe Mesalazine Sales by Application

10 SOUTH AMERICA

  • 10.1 South America Mesalazine Market Size YoY Growth 2016-2027
  • 10.2 South America Mesalazine Market Facts & Figures by Country
    • 10.2.1 South America Mesalazine Sales by Country (2016-2027)
    • 10.2.2 South America Mesalazine Revenue by Country (2016-2027)
  • 10.3 South America Mesalazine Sales by Type
  • 10.4 South America Mesalazine Sales by Application

11 MIDDLE EAST AND AFRICA

  • 11.1 South America Mesalazine Market Size YoY Growth 2016-2027
  • 11.2 Middle East and Africa Mesalazine Market Facts & Figures by Country
    • 11.2.1 Middle East and Africa Mesalazine Sales by Country (2016-2027)
    • 11.2.2 Middle East and Africa Mesalazine Revenue by Country (2016-2027)
  • 11.3 Middle East and Africa Mesalazine Sales by Type
  • 11.4 Middle East and Africa Mesalazine Sales by Application

12 SUPPLY CHAIN AND SALES CHANNEL ANALYSIS

  • 12.1 Mesalazine Supply Chain Analysis
  • 12.2 Mesalazine Key Raw Materials and Upstream Suppliers
  • 12.3 Manufacturing Process Analysis of Mesalazine
  • 12.4 Mesalazine Clients Analysis
  • 12.5 Mesalazine Sales Channel and Sales Model Analysis
    • 12.5.1 Mesalazine Distribution Channel Analysis: Indirect Sales VS Direct Sales
    • 12.5.2 Mesalazine Distribution Channel Analysis: Online Sales VS Offline Sales
    • 12.5.3 Mesalazine Distributors

13 MESALAZINE MARKET DYNAMICS

  • 13.1 Mesalazine Industry Trends
  • 13.2 Mesalazine Market Opportunities and Drivers
  • 13.3 Mesalazine Market Challenges

14 RESEARCH FINDINGS AND CONCLUSION

15 APPENDIX

  • 15.1 Research Methodology
    • 15.1.1 Methodology/Research Approach
    • 15.1.2 Data Source
  • 15.2 Author Details
  • 15.3 Disclaimer

LIST OF TABLES

  • Table 1. Global Mesalazine Market Size Growth Rate by Type (US$ Million): 2021 VS 2027
  • Table 2. Major Manufacturers of Purity ≤97%
  • Table 3. Major Manufacturers of Purity ≤98%
  • Table 4. Major Manufacturers of Purity ≤99%
  • Table 5. Global Mesalazine Market Size Growth by Application (US$ Million): 2021 VS 2027
  • Table 6. Mesalazine Drug Information
  • Table 7. Global Mesalazine Market Size by Region (US$ Million): 2021 VS 2027
  • Table 8. Global Mesalazine Sales by Region (2016-2021) & (MT)
  • Table 9. Global Mesalazine Sales Forecast by Region (2022-2027) & (MT)
  • Table 10. Global Mesalazine Revenue by Region (2016-2021) & (US$ Million)
  • Table 11. Global Mesalazine Revenue Forecast by Region (2022-2027) & (US$ Million)
  • Table 12. Global Mesalazine Sales by Manufacturer (2016-2021) & (MT)
  • Table 13. Global Mesalazine Sales Share by Manufacturer (2016-2021)
  • Table 14. Mesalazine Revenue by Manufacturer (2016-2021) & (US$ Million)
  • Table 15. Mesalazine Revenue Share by Manufacturer (2016-2021)
  • Table 16. Key Manufacturers Mesalazine Price (2016-2021) & (USD/Kg)
  • Table 17. Ranking of Global Top Mesalazine Manufacturers by Revenue (US$ Million) in 2020
  • Table 18. Global Mesalazine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
  • Table 19. Global Mesalazine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mesalazine as of 2019)
  • Table 20. Mesalazine Manufacturers Manufacturing Base Distribution and Headquarters
  • Table 21. Manufacturers Mesalazine Product Type
  • Table 22. Established Date of International Manufacturers in Mesalazine Market
  • Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
  • Table 24. PharmaZell Corporation Information
  • Table 25. PharmaZell Description and Business Overview
  • Table 26. PharmaZell Mesalazine Product
  • Table 27. PharmaZell Mesalazine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
  • Table 28. PharmaZell Mesalazine Revenue (US$ Million) and Market Share by Product
  • Table 29. PharmaZell Mesalazine Revenue (US$ Million) and Market Share by Application
  • Table 30. PharmaZell Mesalazine Revenue (US$ Million) and Market Share by Geographic Area
  • Table 31. PharmaZell Mesalazine Revenue (US$ Million) and Market Share by Sales Channel
  • Table 32. PharmaZell Recent Developments
  • Table 33. Syntese A/S Corporation Information
  • Table 34. Syntese A/S Description and Business Overview
  • Table 35. Syntese A/S Mesalazine Product
  • Table 36. Syntese A/S Mesalazine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
  • Table 37. Syntese A/S Mesalazine Revenue (US$ Million) and Market Share by Product
  • Table 38. Syntese A/S Mesalazine Revenue (US$ Million) and Market Share by Application
  • Table 39. Syntese A/S Mesalazine Revenue (US$ Million) and Market Share by Geographic Area
  • Table 40. Syntese A/S Mesalazine Revenue (US$ Million) and Market Share by Sales Channel
  • Table 41. Cambrex Corporation Information
  • Table 42. Cambrex Corporation Description and Business Overview
  • Table 43. Cambrex Corporation Mesalazine Product
  • Table 44. Cambrex Corporation Mesalazine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
  • Table 45. Cambrex Corporation Mesalazine Revenue (US$ Million) and Market Share by Product
  • Table 46. Cambrex Corporation Mesalazine Revenue (US$ Million) and Market Share by Application
  • Table 47. Cambrex Corporation Mesalazine Revenue (US$ Million) and Market Share by Geographic Area
  • Table 48. Cambrex Corporation Mesalazine Revenue (US$ Million) and Market Share by Sales Channel
  • Table 49. Cambrex Corporation Recent Developments
  • Table 50. Divis Laboratories Corporation Information
  • Table 51. Divis Laboratories Description and Business Overview
  • Table 52. Divis Laboratories Mesalazine Product
  • Table 53. Divis Laboratories Mesalazine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
  • Table 54. Divis Laboratories Mesalazine Revenue (US$ Million) and Market Share by Product
  • Table 55. Divis Laboratories Mesalazine Revenue (US$ Million) and Market Share by Application
  • Table 56. Divis Laboratories Mesalazine Revenue (US$ Million) and Market Share by Geographic Area
  • Table 57. Divis Laboratories Mesalazine Revenue (US$ Million) and Market Share by Sales Channel
  • Table 58. Chemi SpA Corporation Information
  • Table 59. Chemi SpA Description and Business Overview
  • Table 60. Chemi SpA Mesalazine Product
  • Table 61. Chemi SpA Mesalazine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
  • Table 62. Chemi SpA Mesalazine Revenue (US$ Million) and Market Share by Product
  • Table 63. Chemi SpA Mesalazine Revenue (US$ Million) and Market Share by Application
  • Table 64. Chemi SpA Mesalazine Revenue (US$ Million) and Market Share by Geographic Area
  • Table 65. Chemi SpA Mesalazine Revenue (US$ Million) and Market Share by Sales Channel
  • Table 66. Ipca Laboratories Corporation Information
  • Table 67. Ipca Laboratories Description and Business Overview
  • Table 68. Ipca Laboratories Mesalazine Product
  • Table 69. Ipca Laboratories Mesalazine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
  • Table 70. Ipca Laboratories Mesalazine Revenue (US$ Million) and Market Share by Product
  • Table 71. Ipca Laboratories Mesalazine Revenue (US$ Million) and Market Share by Application
  • Table 72. Ipca Laboratories Mesalazine Revenue (US$ Million) and Market Share by Geographic Area
  • Table 73. Ipca Laboratories Mesalazine Revenue (US$ Million) and Market Share by Sales Channel
  • Table 74. Hangzhou Brother Corporation Information
  • Table 75. Hangzhou Brother Description and Business Overview
  • Table 76. Hangzhou Brother Mesalazine Product
  • Table 77. Hangzhou Brother Mesalazine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
  • Table 78. Hangzhou Brother Mesalazine Revenue (US$ Million) and Market Share by Product
  • Table 79. Hangzhou Brother Mesalazine Revenue (US$ Million) and Market Share by Application
  • Table 80. Hangzhou Brother Mesalazine Revenue (US$ Million) and Market Share by Geographic Area
  • Table 81. Hangzhou Brother Mesalazine Revenue (US$ Million) and Market Share by Sales Channel
  • Table 82. Lianyungang Fengheng Biopharm Corporation Information
  • Table 83. Lianyungang Fengheng Biopharm Description and Business Overview
  • Table 84. Lianyungang Fengheng Biopharm Mesalazine Product
  • Table 85. Lianyungang Fengheng Biopharm Mesalazine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
  • Table 86. Lianyungang Fengheng Biopharm Mesalazine Revenue (US$ Million) and Market Share by Product
  • Table 87. Lianyungang Fengheng Biopharm Mesalazine Revenue (US$ Million) and Market Share by Application
  • Table 88. Lianyungang Fengheng Biopharm Mesalazine Revenue (US$ Million) and Market Share by Geographic Area
  • Table 89. Lianyungang Fengheng Biopharm Mesalazine Revenue (US$ Million) and Market Share by Sales Channel
  • Table 90. Lasa Loboratory Corporation Information
  • Table 91. Lasa Loboratory Description and Business Overview
  • Table 92. Lasa Loboratory Mesalazine Product
  • Table 93. Lasa Loboratory Mesalazine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
  • Table 94. Lasa Loboratory Mesalazine Revenue (US$ Million) and Market Share by Product
  • Table 95. Lasa Loboratory Mesalazine Revenue (US$ Million) and Market Share by Application
  • Table 96. Lasa Loboratory Mesalazine Revenue (US$ Million) and Market Share by Geographic Area
  • Table 97. Lasa Loboratory Mesalazine Revenue (US$ Million) and Market Share by Sales Channel
  • Table 98. Corden Pharma Bergamo Corporation Information
  • Table 99. Corden Pharma Bergamo Description and Business Overview
  • Table 100. Corden Pharma Bergamo Mesalazine Product
  • Table 101. Corden Pharma Bergamo Mesalazine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
  • Table 102. Corden Pharma Bergamo Mesalazine Revenue (US$ Million) and Market Share by Product
  • Table 103. Corden Pharma Bergamo Mesalazine Revenue (US$ Million) and Market Share by Application
  • Table 104. Corden Pharma Bergamo Mesalazine Revenue (US$ Million) and Market Share by Geographic Area
  • Table 105. Corden Pharma Bergamo Mesalazine Revenue (US$ Million) and Market Share by Sales Channel
  • Table 106. Corden Pharma Bergamo Recent Developments
  • Table 107. Erregierre SpA Corporation Information
  • Table 108. Erregierre SpA Description and Business Overview
  • Table 109. Erregierre SpA Mesalazine Product
  • Table 110. Erregierre SpA Mesalazine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
  • Table 111. Erregierre SpA Mesalazine Revenue (US$ Million) and Market Share by Product
  • Table 112. Erregierre SpA Mesalazine Revenue (US$ Million) and Market Share by Application
  • Table 113. Erregierre SpA Mesalazine Revenue (US$ Million) and Market Share by Geographic Area
  • Table 114. Erregierre SpA Mesalazine Revenue (US$ Million) and Market Share by Sales Channel
  • Table 115. CTX Lifescience Corporation Information
  • Table 116. CTX Lifescience Description and Business Overview
  • Table 117. CTX Lifescience Mesalazine Product
  • Table 118. CTX Lifescience Mesalazine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
  • Table 119. CTX Lifescience Mesalazine Revenue (US$ Million) and Market Share by Product
  • Table 120. CTX Lifescience Mesalazine Revenue (US$ Million) and Market Share by Application
  • Table 121. CTX Lifescience Mesalazine Revenue (US$ Million) and Market Share by Geographic Area
  • Table 122. CTX Lifescience Mesalazine Revenue (US$ Million) and Market Share by Sales Channel
  • Table 123. Ishita Active Pharma Ingredients Corporation Information
  • Table 124. Ishita Active Pharma Ingredients Description and Business Overview
  • Table 125. Ishita Active Pharma Ingredients Mesalazine Product
  • Table 126. Ishita Active Pharma Ingredients Mesalazine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
  • Table 127. Ishita Active Pharma Ingredients Mesalazine Revenue (US$ Million) and Market Share by Product
  • Table 128. Ishita Active Pharma Ingredients Mesalazine Revenue (US$ Million) and Market Share by Application
  • Table 129. Ishita Active Pharma Ingredients Mesalazine Revenue (US$ Million) and Market Share by Geographic Area
  • Table 130. Ishita Active Pharma Ingredients Mesalazine Revenue (US$ Million) and Market Share by Sales Channel
  • Table 131. YC Biotech (Jiangsu) Corporation Information
  • Table 132. YC Biotech (Jiangsu) Description and Business Overview
  • Table 133. YC Biotech (Jiangsu) Mesalazine Product
  • Table 134. YC Biotech (Jiangsu) Mesalazine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
  • Table 135. YC Biotech (Jiangsu) Mesalazine Revenue (US$ Million) and Market Share by Product
  • Table 136. YC Biotech (Jiangsu) Mesalazine Revenue (US$ Million) and Market Share by Application
  • Table 137. YC Biotech (Jiangsu) Mesalazine Revenue (US$ Million) and Market Share by Geographic Area
  • Table 138. YC Biotech (Jiangsu) Mesalazine Revenue (US$ Million) and Market Share by Sales Channel
  • Table 139. Xinxiang Tianfeng Fine Chemical Corporation Information
  • Table 140. Xinxiang Tianfeng Fine Chemical Description and Business Overview
  • Table 141. Xinxiang Tianfeng Fine Chemical Mesalazine Product
  • Table 142. Xinxiang Tianfeng Fine Chemical Mesalazine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
  • Table 143. Xinxiang Tianfeng Fine Chemical Mesalazine Revenue (US$ Million) and Market Share by Product
  • Table 144. Xinxiang Tianfeng Fine Chemical Mesalazine Revenue (US$ Million) and Market Share by Application
  • Table 145. Xinxiang Tianfeng Fine Chemical Mesalazine Revenue (US$ Million) and Market Share by Geographic Area
  • Table 146. Xinxiang Tianfeng Fine Chemical Mesalazine Revenue (US$ Million) and Market Share by Sales Channel
  • Table 147. Global Mesalazine Sales by Type (2016-2021) & (MT)
  • Table 148. Global Mesalazine Sales Forecast by Type (2022-2027) & (MT)
  • Table 149. Global Mesalazine Revenue by Type (2016-2021) & (US$ Million)
  • Table 150. Global Mesalazine Revenue Forecast by Type (2022-2027) & (US$ Million)
  • Table 151. Mesalazine Average Selling Price (ASP) by Type (2016-2021) & (USD/Kg)
  • Table 152. Mesalazine Average Selling Price (ASP) by Type (2022-2027) & (USD/Kg)
  • Table 153. Global Mesalazine Sales by Application (2016-2021) & (MT)
  • Table 154. Global Mesalazine Sales Forecast by Application (2022-2027) & (MT)
  • Table 155. Global Mesalazine Revenue by Application (2016-2021) & (US$ Million)
  • Table 156. Global Mesalazine Revenue Forecast by Application (2022-2027) & (US$ Million)
  • Table 157. Mesalazine Average Selling Price (ASP) by Application (2016-2021) & (USD/Kg)
  • Table 158. Mesalazine Average Selling Price (ASP) by Application (2022-2027) & (USD/Kg)
  • Table 159. North America Mesalazine Sales by Country (2016-2021) & (MT)
  • Table 160. North America Mesalazine Sales by Country (2022-2027) & (MT)
  • Table 161. North America Mesalazine Revenue by Country (2016-2021) & (US$ Million)
  • Table 162. North America Mesalazine Revenue by Country (2022-2027) & (US$ Million)
  • Table 163. North America Mesalazine Sales by Type (2016-2021) & (MT)
  • Table 164. North America Mesalazine Sales Market Share by Type (2016-2021)
  • Table 165. North America Mesalazine Sales by Application (2016-2021) & (MT)
  • Table 166. North America Mesalazine Sales Market Share by Application (2016-2021)
  • Table 167. Asia-Pacific Mesalazine Sales by Region (2016-2021) & (MT)
  • Table 168. Asia-Pacific Mesalazine Sales by Region (2022-2027) & (MT)
  • Table 169. Asia-Pacific Mesalazine Revenue by Region (2016-2027) & (US$ Million)
  • Table 170. Asia-Pacific Mesalazine Revenue by Region (2022-2027) & (US$ Million)
  • Table 171. Asia-Pacific Mesalazine Sales by Type (2016-2021) & (MT)
  • Table 172. Asia-Pacific Mesalazine Sales Market Share by Type (2016-2021)
  • Table 173. Asia-Pacific Mesalazine Sales by Application (2016-2021) & (MT)
  • Table 174. Asia-Pacific Mesalazine Sales Market Share by Application (2016-2021)
  • Table 175. Europe Mesalazine Sales by Country (2016-2021) & (MT)
  • Table 176. Europe Mesalazine Sales by Country (2022-2027) & (MT)
  • Table 177. Europe Mesalazine Revenue by Country (2016-2021) & (US$ Million)
  • Table 178. Europe Mesalazine Revenue by Country (2022-2027) & (US$ Million)
  • Table 179. Europe Mesalazine Sales by Type (2016-2021) & (MT)
  • Table 180. Europe Mesalazine Sales Market Share by Type (2016-2021)
  • Table 181. Europe Mesalazine Sales by Application (2016-2021) & (MT)
  • Table 182. Europe Mesalazine Sales Market Share by Application (2016-2021)
  • Table 183. South America Mesalazine Sales by Country (2016-2021) & (MT)
  • Table 184. South America Mesalazine Sales by Country (2022-2027) & (MT)
  • Table 185. South America Mesalazine Revenue by Country (2016-2021) & (US$ Million)
  • Table 186. South America Mesalazine Revenue by Country (2022-2027) & (US$ Million)
  • Table 187. South America Mesalazine Sales by Type (2016-2021) & (MT)
  • Table 188. South America Mesalazine Sales Market Share by Type (2016-2021)
  • Table 189. South America Mesalazine Sales by Application (2016-2021) & (MT)
  • Table 190. South America Mesalazine Sales Market Share by Application (2016-2021)
  • Table 191. Middle East and Africa Mesalazine Sales by Country (2016-2021) & (MT)
  • Table 192. Middle East and Africa Mesalazine Sales by Country (2022-2027) & (MT)
  • Table 193. Middle East and Africa Mesalazine Revenue by Country (2016-2021) & (US$ Million)
  • Table 194. Middle East and Africa Mesalazine Revenue by Country (2022-2027) & (US$ Million)
  • Table 195. Middle East and Africa Mesalazine Sales by Type (2016-2021) & (MT)
  • Table 196. Middle East and Africa Mesalazine Sales Market Share by Type (2016-2021)
  • Table 197. Middle East and Africa Mesalazine Sales by Application (2016-2021) & (MT)
  • Table 198. Middle East and Africa Mesalazine Sales Market Share by Application (2016-2021)
  • Table 199. Mesalazine Key Raw Materials, Industry Status and Trend
  • Table 200. Mesalazine Key Raw Materials and Upstream Suppliers
  • Table 201. Mesalazine Clients Status and Trend
  • Table 202. Mesalazine Typical Clients
  • Table 203. Mesalazine Distributors
  • Table 204. Mesalazine Market Trends
  • Table 205. Mesalazine Market Opportunities
  • Table 206. Mesalazine Market Drivers
  • Table 207. Mesalazine Market Challenges
  • Table 208. Research Programs/Design for This Report
  • Table 209. Key Data Information from Secondary Sources
  • Table 210. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Mesalazine Basic Information
  • Figure 2. Mesalazine Basic Information
  • Figure 3. Global Mesalazine Revenue Market Share by Type in 2020 & 2027
  • Figure 4. Global Mesalazine Revenue Market Share by Application in 2020 & 2027
  • Figure 5. Tablets
  • Figure 6. Capsules
  • Figure 7. Pellet and Granule
  • Figure 8. Suppository
  • Figure 9. Enema
  • Figure 10. Mesalazine Report Years Considered
  • Figure 11. Global Mesalazine Revenue, (US$ Million), 2016 VS 2021 VS 2027
  • Figure 12. Global Mesalazine Market Size 2016-2027 (US$ Million)
  • Figure 13. Global Mesalazine Sales 2016-2027 (MT)
  • Figure 14. Global Mesalazine Market Size (US$ Million) Market Share by Region: 2021 Versus 2027
  • Figure 15. Global Mesalazine Sales Market Share Forecast by Region (2016-2027)
  • Figure 16. Global Mesalazine Revenue Market Share by Region (2016-2027)
  • Figure 17. Global Mesalazine Sales Share by Manufacturer in 2020
  • Figure 18. Global Mesalazine Sales Share by Manufacturer in 2020
  • Figure 19. Mesalazine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2020
  • Figure 20. Global Mesalazine Sales Market Share Forecast by Type (2016-2027)
  • Figure 21. Global Mesalazine Revenue Market Share Forecast by Type (2016-2027)
  • Figure 22. Global Mesalazine Sales Market Share Forecast by Application (2016-2027)
  • Figure 23. Global Mesalazine Revenue Market Share Forecast by Application (2016-2027)
  • Figure 24. North America Mesalazine Revenue 2016-2027 (US$ Million)
  • Figure 25. North America Mesalazine Sales Market Share by Country (2016-2027)
  • Figure 26. North America Mesalazine Revenue Market Share by Country (2016-2027)
  • Figure 27. Asia-Pacific Mesalazine Revenue 2016-2027 (US$ Million)
  • Figure 28. Asia Pacific Mesalazine Sales Market Share by Country (2016-2027)
  • Figure 29. Asia Pacific Mesalazine Revenue Market Share by Country (2016-2027)
  • Figure 30. Europe Mesalazine Revenue Growth Rate 2016-2027 (US$ Million)
  • Figure 31. Europe Mesalazine Sales Market Share by Country (2016-2027)
  • Figure 32. Europe Mesalazine Revenue Market Share by Country (2016-2027)
  • Figure 33. South America Mesalazine Revenue Growth Rate 2016-2027 (US$ Million)
  • Figure 34. South America Mesalazine Sales Market Share by Country (2016-2027)
  • Figure 35. South America Mesalazine Revenue Market Share by Country (2016-2021)
  • Figure 36. Middle East and Africa Mesalazine Revenue Growth Rate 2016-2027 (US$ Million)
  • Figure 37. Middle East and Africa Mesalazine Sales Market Share by Country (2016-2027)
  • Figure 38. Middle East and Africa Mesalazine Revenue Market Share by Country (2016-2027)
  • Figure 39. Mesalazine Supply Chain (Upstream and Downstream Market)
  • Figure 40. Manufacturing Process Analysis of Mesalazine
  • Figure 41. Mesalazine Distribution Channels
  • Figure 42. Global Mesalazine Percentage 2016-2027: Indirect Sales VS Direct Sales
  • Figure 43. Global Mesalazine Percentage 2016-2027: Online Sales VS Offline Sales
  • Figure 44. Bottom-up and Top-down Approaches for This Report
  • Figure 45. Data Triangulation
  • Figure 46. Key Executives Interviewed